Ds Healthcare Group Inc (DSKX) 0.75 $DSKX
DS Healthcare wins regulatory approval to market its Spectral.LASH Eyelash extender in Brazil
M2 - Wed Nov 26, 4:06AM CST
Personal care products company DS Healthcare Group (NasdaqCM
SKX) revealed on Tuesday the receipt of approval to market its Spectral.LASHeyelash extender product in Brazil.
DSKX: 0.75 (-0.01)
DS Healthcare Receives Regulatory Approval in Brazil to Market its Spectral.LASH Eyelash Extender
GlobeNewswire - Tue Nov 25, 8:45AM CST
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced that the Brazilian Health Surveillance Agency, ANVISA, has approved the Company's Spectral.LASHeyelash extender product for marketing in Brazil.
DSKX: 0.75 (-0.01)
DS Healthcare Group CEO Daniel Khesin featured on The Gray Zone
PR Newswire - Mon Nov 17, 1:48PM CST
DS Healthcare Group CEO Daniel Khesin was featured on The Gray Zone on 880 The Biz on Nov. 14 to announce the launch of the DS Laboratories Hair Recovery Clinic (www.dshairclinic.com) in Coral Gables.
DSKX: 0.75 (-0.01)
DS Healthcare revenues up 2.4% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:58AM CST
DSKX: 0.75 (-0.01)
DS Healthcare misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 7:51AM CST
DSKX: 0.75 (-0.01)
DS Healthcare Group Reports Third Quarter 2014 Financial Results As Company Reaches EBITDAS Profitability
GlobeNewswire - Mon Nov 17, 7:42AM CST
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and nine months ended September 30, 2014.
DSKX: 0.75 (-0.01)
DS Healthcare Group Issues Letter to Shareholders
GlobeNewswire - Fri Nov 14, 8:38AM CST
DS Healthcare Group, Inc. (NASDAQ SKX), a leading developer of personal care and specialty pharmaceutical products, today issued the following letter to shareholders:
DSKX: 0.75 (-0.01)
"New To The Street" Is Back on the Street
Marketwired - Thu Nov 13, 12:40PM CST
"New To The Street" was back on the street in NYC outside the See Thru Equity Conference, seethruequity.com, on 45th Street, interviewing several CEO's who were presenting at the micro-cap conference. We will be featuring these interviews on our website, NewToTheStreet.com on our segment called "On the Street Interviews."
DSKX: 0.75 (-0.01)
"New To The Street" to Broadcast Nationally
Marketwired - Tue Nov 11, 11:04AM CST
"New To The Street" will be airing nationally on the ION Network on December 4, 2014 at 9:30 am reaching 100M households.
DSKX: 0.75 (-0.01)
"New To The Street" Announces Upcoming Episodes, Clients, and Themes
Marketwired - Fri Nov 07, 2:30PM CST
"New To The Street" would like to introduce Hybrid Coating Technologies (OTCQB: HCTI) and its upcoming interview to be broadcast Monday, November 10th at 7:00 am on the ION Network WPXN, as well as our ongoing interviews with VizConnect (OTCQB: VIZC), HydroCarb Energy (OTCQB: HECC) and Larry Isen from the OTC Journal.
DSKX: 0.75 (-0.01)
"New To The Street" Television Show Completes an In-Depth Feature TV Interview With DS Healthcare Group (NASDAQ: DSKX)
Marketwired - Fri Oct 24, 1:48PM CDT
"New To The Street," a television show that profiles public companies across national TV networks and social media channels with in-depth anchor driven reporting, will be airing the first of a six-part series on Monday, October 27, 2014 at 7:00 am on ION's New York Flagship Station WPXN featuring DS Healthcare Group.
DSKX: 0.75 (-0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 11:48AM CDT
SPRO: 1.72 (+0.01), SYNA: 66.39 (-0.69), ISR: 1.62 (-0.02), ADHD: 3.41 (+0.16), VTAE: 22.01 (+0.30), AEHR: 2.65 (-0.05), DSKX: 0.75 (-0.01), AMDA: 0.69 (-0.01), DRIV: 16.89 (+0.31), GIMO: 16.04 (-0.06), CBDE: 0.90 (+0.06), IVC: 16.50 (-0.43), P: 17.35 (-0.12), LAYN: 8.22 (+0.46), BJRI: 48.23 (-0.06), PGI: 10.20 (-0.08), HVB: 25.70 (+0.10), DRYS: 0.86 (-0.05), MMSI: 16.41 (+0.02)
UPDATE: "New to the Street" Locks in Mondays at 7:00am on ION's Flagstaff TV Station WPXN in New York Starting October 20th
Marketwire - Tue Sep 23, 11:56AM CDT
New to the Street will offer weekly access to our bio-type news series interviews with public and private company's CEO's every Monday at 7:00 am.
DSKX: 0.75 (-0.01)
DS Healthcare Group obtains regulatory sales approval in Middle East, reflecting 6% of the worldwide market
M2 - Fri Sep 05, 4:53AM CDT
Topical therapies company DS Healthcare Group reported on Thursday the receipt of regulatory approval for the sale of its products line in Middle East following its recent expansion into Brazil and China.
DSKX: 0.75 (-0.01)
DS Healthcare Group obtains regulatory approval in Middle East
GlobeNewswire - Thu Sep 04, 7:26AM CDT
This agreement comes on the heels of the Company's recent expansion into Brazil and China. International sales are a key driver of the Company's growth, as its breakthrough products are in high demand in Canada, Mexico, the UK, and Australia.
DSKX: 0.75 (-0.01)
DS Healthcare Group to Open its First DS Laboratories Hair Loss Clinic Offering Patients Unique Personalized Therapies for Hair Loss
GlobeNewswire - Tue Sep 02, 7:07AM CDT
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products and specialty pharmaceuticals, today announced it will open its first DS Laboratories Hair Loss Clinic in Miami, Florida. Slated to open in the fourth quarter of 2014, the clinic will provide unique therapies and treatment options for patients who desire the most comprehensive approach to treating hair loss. A team of healthcare professionals led by a medical doctor will provide customized solutions with the most advanced proven technologies developed through DS Healthcare's clinical research to restore a full head of hair.
DSKX: 0.75 (-0.01)
DS Healthcare Group (DSKX) is Undervalued With Good Seasonality.
M2 - Fri Aug 22, 7:27AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has updated its research report today on DS Healthcare Group (NASDAQ: DSKX). The report highlights the short term bullish seasonality that has emerged, the SqueezeTrigger Price of $2.51 and the projected fundamental valuation of $5.50 per share.
DSKX: 0.75 (-0.01)
BUYINS.NET Issues DS Healthcare Group (DSKX) SqueezeTrigger Report
M2 - Fri Aug 15, 7:20AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on DS Healthcare Group (NASDAQ: DSKX) after releasing the latest short sale data through August 13, 2014. The total aggregate number of shares shorted since May 2010 is approximately 2.08 million shares. Approximately 30% of daily trading volume is short selling. The SqueezeTrigger price for all DSKX shares shorted is $2.51. A short squeeze is expected to begin when shares of DSKX close above the $2.51 SqueezeTrigger price.
DSKX: 0.75 (-0.01)
DS Healthcare Group Reports Second Quarter 2014 Financial Results
GlobeNewswire - Fri Aug 15, 7:15AM CDT
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and six months ended June 30, 2014.
DSKX: 0.75 (-0.01)
DS Healthcare signs third distribution agreement in Brazil for personal care products
M2 - Thu Aug 07, 4:11AM CDT
Specialist pharmaceuticals company DS Healthcare Group (NasdaqCM SKX) announced on Wednesday that it signed a distribution agreement the Rio de Janerio-based wholesale pharmacy Drogaria Venancio.
DSKX: 0.75 (-0.01)
DS Healthcare wins regulatory approval to market its Spectral.LASH Eyelash extender in Brazil
M2 - Wed Nov 26, 4:06AM CST
Personal care products company DS Healthcare Group (NasdaqCM
SKX) revealed on Tuesday the receipt of approval to market its Spectral.LASHeyelash extender product in Brazil. DSKX: 0.75 (-0.01)
DS Healthcare Receives Regulatory Approval in Brazil to Market its Spectral.LASH Eyelash Extender
GlobeNewswire - Tue Nov 25, 8:45AM CST
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced that the Brazilian Health Surveillance Agency, ANVISA, has approved the Company's Spectral.LASHeyelash extender product for marketing in Brazil.
DSKX: 0.75 (-0.01)
DS Healthcare Group CEO Daniel Khesin featured on The Gray Zone
PR Newswire - Mon Nov 17, 1:48PM CST
DS Healthcare Group CEO Daniel Khesin was featured on The Gray Zone on 880 The Biz on Nov. 14 to announce the launch of the DS Laboratories Hair Recovery Clinic (www.dshairclinic.com) in Coral Gables.
DSKX: 0.75 (-0.01)
DS Healthcare revenues up 2.4% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:58AM CST
DSKX: 0.75 (-0.01)
DS Healthcare misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 7:51AM CST
DSKX: 0.75 (-0.01)
DS Healthcare Group Reports Third Quarter 2014 Financial Results As Company Reaches EBITDAS Profitability
GlobeNewswire - Mon Nov 17, 7:42AM CST
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and nine months ended September 30, 2014.
DSKX: 0.75 (-0.01)
DS Healthcare Group Issues Letter to Shareholders
GlobeNewswire - Fri Nov 14, 8:38AM CST
DS Healthcare Group, Inc. (NASDAQ
SKX), a leading developer of personal care and specialty pharmaceutical products, today issued the following letter to shareholders: DSKX: 0.75 (-0.01)
"New To The Street" Is Back on the Street
Marketwired - Thu Nov 13, 12:40PM CST
"New To The Street" was back on the street in NYC outside the See Thru Equity Conference, seethruequity.com, on 45th Street, interviewing several CEO's who were presenting at the micro-cap conference. We will be featuring these interviews on our website, NewToTheStreet.com on our segment called "On the Street Interviews."
DSKX: 0.75 (-0.01)
"New To The Street" to Broadcast Nationally
Marketwired - Tue Nov 11, 11:04AM CST
"New To The Street" will be airing nationally on the ION Network on December 4, 2014 at 9:30 am reaching 100M households.
DSKX: 0.75 (-0.01)
"New To The Street" Announces Upcoming Episodes, Clients, and Themes
Marketwired - Fri Nov 07, 2:30PM CST
"New To The Street" would like to introduce Hybrid Coating Technologies (OTCQB: HCTI) and its upcoming interview to be broadcast Monday, November 10th at 7:00 am on the ION Network WPXN, as well as our ongoing interviews with VizConnect (OTCQB: VIZC), HydroCarb Energy (OTCQB: HECC) and Larry Isen from the OTC Journal.
DSKX: 0.75 (-0.01)
"New To The Street" Television Show Completes an In-Depth Feature TV Interview With DS Healthcare Group (NASDAQ: DSKX)
Marketwired - Fri Oct 24, 1:48PM CDT
"New To The Street," a television show that profiles public companies across national TV networks and social media channels with in-depth anchor driven reporting, will be airing the first of a six-part series on Monday, October 27, 2014 at 7:00 am on ION's New York Flagship Station WPXN featuring DS Healthcare Group.
DSKX: 0.75 (-0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 11:48AM CDT
SPRO: 1.72 (+0.01), SYNA: 66.39 (-0.69), ISR: 1.62 (-0.02), ADHD: 3.41 (+0.16), VTAE: 22.01 (+0.30), AEHR: 2.65 (-0.05), DSKX: 0.75 (-0.01), AMDA: 0.69 (-0.01), DRIV: 16.89 (+0.31), GIMO: 16.04 (-0.06), CBDE: 0.90 (+0.06), IVC: 16.50 (-0.43), P: 17.35 (-0.12), LAYN: 8.22 (+0.46), BJRI: 48.23 (-0.06), PGI: 10.20 (-0.08), HVB: 25.70 (+0.10), DRYS: 0.86 (-0.05), MMSI: 16.41 (+0.02)
UPDATE: "New to the Street" Locks in Mondays at 7:00am on ION's Flagstaff TV Station WPXN in New York Starting October 20th
Marketwire - Tue Sep 23, 11:56AM CDT
New to the Street will offer weekly access to our bio-type news series interviews with public and private company's CEO's every Monday at 7:00 am.
DSKX: 0.75 (-0.01)
DS Healthcare Group obtains regulatory sales approval in Middle East, reflecting 6% of the worldwide market
M2 - Fri Sep 05, 4:53AM CDT
Topical therapies company DS Healthcare Group reported on Thursday the receipt of regulatory approval for the sale of its products line in Middle East following its recent expansion into Brazil and China.
DSKX: 0.75 (-0.01)
DS Healthcare Group obtains regulatory approval in Middle East
GlobeNewswire - Thu Sep 04, 7:26AM CDT
This agreement comes on the heels of the Company's recent expansion into Brazil and China. International sales are a key driver of the Company's growth, as its breakthrough products are in high demand in Canada, Mexico, the UK, and Australia.
DSKX: 0.75 (-0.01)
DS Healthcare Group to Open its First DS Laboratories Hair Loss Clinic Offering Patients Unique Personalized Therapies for Hair Loss
GlobeNewswire - Tue Sep 02, 7:07AM CDT
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products and specialty pharmaceuticals, today announced it will open its first DS Laboratories Hair Loss Clinic in Miami, Florida. Slated to open in the fourth quarter of 2014, the clinic will provide unique therapies and treatment options for patients who desire the most comprehensive approach to treating hair loss. A team of healthcare professionals led by a medical doctor will provide customized solutions with the most advanced proven technologies developed through DS Healthcare's clinical research to restore a full head of hair.
DSKX: 0.75 (-0.01)
DS Healthcare Group (DSKX) is Undervalued With Good Seasonality.
M2 - Fri Aug 22, 7:27AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has updated its research report today on DS Healthcare Group (NASDAQ: DSKX). The report highlights the short term bullish seasonality that has emerged, the SqueezeTrigger Price of $2.51 and the projected fundamental valuation of $5.50 per share.
DSKX: 0.75 (-0.01)
BUYINS.NET Issues DS Healthcare Group (DSKX) SqueezeTrigger Report
M2 - Fri Aug 15, 7:20AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on DS Healthcare Group (NASDAQ: DSKX) after releasing the latest short sale data through August 13, 2014. The total aggregate number of shares shorted since May 2010 is approximately 2.08 million shares. Approximately 30% of daily trading volume is short selling. The SqueezeTrigger price for all DSKX shares shorted is $2.51. A short squeeze is expected to begin when shares of DSKX close above the $2.51 SqueezeTrigger price.
DSKX: 0.75 (-0.01)
DS Healthcare Group Reports Second Quarter 2014 Financial Results
GlobeNewswire - Fri Aug 15, 7:15AM CDT
DS Healthcare Group, Inc. (NASDAQ: DSKX), a leading developer of personal care products, today announced financial results for the three and six months ended June 30, 2014.
DSKX: 0.75 (-0.01)
DS Healthcare signs third distribution agreement in Brazil for personal care products
M2 - Thu Aug 07, 4:11AM CDT
Specialist pharmaceuticals company DS Healthcare Group (NasdaqCM
SKX) announced on Wednesday that it signed a distribution agreement the Rio de Janerio-based wholesale pharmacy Drogaria Venancio. DSKX: 0.75 (-0.01)
